Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 3;11(8):e0005424.
doi: 10.1371/journal.pntd.0005424. eCollection 2017 Aug.

The global burden of disease study 2013: What does it mean for the NTDs?

Jennifer R Herricks  1   2 , Peter J Hotez  1   2   3   4   5 , Valentine Wanga  6 , Luc E Coffeng  6   7 , Juanita A Haagsma  6   7 , María-Gloria Basáñez  8 , Geoffrey Buckle  9 , Christine M Budke  10 , Hélène Carabin  11 , Eric M Fèvre  12   13 , Thomas Fürst  14   15   16 , Yara A Halasa  17 , Charles H King  18 , Michele E Murdoch  19 , Kapa D Ramaiah  20 , Donald S Shepard  17 , Wilma A Stolk  6 , Eduardo A Undurraga  17 , Jeffrey D Stanaway  6 , Mohsen Naghavi  6 , Christopher J L Murray  6
Affiliations

The global burden of disease study 2013: What does it mean for the NTDs?

Jennifer R Herricks et al. PLoS Negl Trop Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

PJH is principal investigator and patentholder on various vaccines in development that would provide protection from neglected tropical diseases. DSS has received grant funding from Sanofi Pasteur. The other authors declare no conflicts of interest.

Figures

Fig 1
Fig 1. Global dengue incidence per 100,000 person-years in 2013.
Adapted from Stanaway et al. [40]. NOTE: No estimates are available for Western Sahara as it was not a modeled location in the Global Burden of Disease Study (GBD) 2013.
Fig 2
Fig 2. Global cutaneous/mucocutaneous leishmaniasis prevalence per 100,000 population in 2013.
NOTE: No estimates are available for Western Sahara as it was not a modeled location in the Global Burden of Disease Study (GBD) 2013.
Fig 3
Fig 3. Countries with highest NTD prevalence in 2013.
Countries with the highest prevalence (per 100,000 population) for the diseases indicated and the estimated prevalence in each country. Countries are color coded by Global Burden of Disease Study (GBD) regions. Abbreviations: CAR, Central African Republic; DRC, Democratic Republic of the Congo; STP, São Tomé and Principe. *Also includes mucocutaneous leishmaniasis, **Incidence rather than prevalence.
Fig 4
Fig 4. Countries with highest absolute number of NTD cases in 2013.
Countries with the highest number of absolute cases for the diseases indicated and the estimated numbers in each country. These data are also available from the Institute for Health Metrics and Evaluation (IHME) website. Countries are color coded by Global Burden of Disease Study (GBD) regions. Abbreviations: CAR, Central African Republic; DRC, Democratic Republic of the Congo; STP, São Tomé and Principe. *Also includes mucocutaneous leishmaniasis, **Incident cases rather than prevalent cases, NOTE: As in Table 1, only symptomatic cases are estimated for dengue, trachoma, cystic echinococcosis, cysticercosis, and rabies.
Fig 5
Fig 5. Deaths per 100,000 population by age and sex in 2013.
The data used to generate this figure are also available on the Institute for Health Metrics and Evaluation (IHME) website.
Fig 6
Fig 6. Disability-adjusted life years (DALYs) per 100,000 population by age and gender in 2013.
The estimates used to generate this figure are also available on the Institute for Health Metrics and Evaluation (IHME) website.
Fig 7
Fig 7. Proportional representation of disability-adjusted life years (DALYs) (per 100,000 population) from all NTDs combined in 1990 and 2013 by Global Burden of Disease Study (GBD) super region.
Each bar represents the total disability-adjusted life years (DALYs) per 100,000 population for WHO-prioritized NTDs combined by GBD super region, broken down by percentage of years of life lost (YLLs) (darker shading) and years lived with disability (YLDs) (lighter shading). GBD-estimated numbers for DALY, YLL, and YLD rates for each super region in 1990 and 2013 are shown in the key.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis. 2014;8(7):e2865 doi: 10.1371/journal.pntd.0002865 ; PubMed Central PMCID: PMC4109880. - DOI - PMC - PubMed
    1. Global Burden of Disease DALYS HALE Collaborators, Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–91. doi: 10.1016/S0140-6736(15)61340-X ; PubMed Central PMCID: PMC4673910. - DOI - PMC - PubMed
    1. Global Burden of Disease Study Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4 ; PubMed Central PMCID: PMC4561509. - DOI - PMC - PubMed
    1. Global Burden of Disease Mortality Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117–71. doi: 10.1016/S0140-6736(14)61682-2 ; PubMed Central PMCID: PMC4340604. - DOI - PMC - PubMed
    1. Beyrer C, Villar JC, Suwanvanichkij V, Singh S, Baral SD, Mills EJ. Neglected diseases, civil conflicts, and the right to health. Lancet. 2007;370(9587):619–27. doi: 10.1016/S0140-6736(07)61301-4 . - DOI - PubMed

Publication types

MeSH terms